Cargando…

Combined Metabolomic Analysis of Plasma and Tissue Reveals a Prognostic Risk Score System and Metabolic Dysregulation in Esophageal Squamous Cell Carcinoma

Background: Esophageal squamous cell carcinoma (ESCC) is a gastrointestinal malignancy with a poor prognosis. Although studies have shown metabolic reprogramming to be linked to ESCC development, no prognostic metabolic biomarkers or potential therapeutic metabolic targets have been identified. Meth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zhongjian, Dai, Yalan, Huang, Xiancong, Chen, Keke, Gao, Yun, Li, Na, Wang, Ding, Chen, Aiping, Yang, Qingxia, Hong, Yanjun, Zeng, Su, Mao, Weimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479226/ https://www.ncbi.nlm.nih.gov/pubmed/32984013 http://dx.doi.org/10.3389/fonc.2020.01545

Ejemplares similares

Plasma-metabolite-based machine learning is a promising diagnostic approach for esophageal squamous cell carcinoma investigation
por: Chen, Zhongjian, et al.
Publicado: (2021)

Preoperative serum bilirubin is an independent prognostic factor for curatively resected esophageal squamous cell carcinoma
por: Huang, Xiancong, et al.
Publicado: (2023)

Plasma Metabolomics Reveals Diagnostic Biomarkers and Risk Factors for Esophageal Squamous Cell Carcinoma
por: Yu, Mengjie, et al.
Publicado: (2022)

Roles of circRNA dysregulation in esophageal squamous cell carcinoma tumor microenvironment
por: Li, Jingyi, et al.
Publicado: (2023)

Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Pan Pan, et al.
Publicado: (2022)

Naples Prognostic Score: A Novel Prognostic Score in Predicting Cancer-Specific Survival in Patients With Resected Esophageal Squamous Cell Carcinoma
por: Feng, Ji-Feng, et al.
Publicado: (2021)

Autophagy-Related Three-Gene Prognostic Signature for Predicting Survival in Esophageal Squamous Cell Carcinoma
por: Cui, Heyang, et al.
Publicado: (2021)

Metformin Downregulates PD-L1 Expression in Esophageal Squamous Cell Carcinoma by Inhibiting IL-6 Signaling Pathway
por: Lu, Yao, et al.
Publicado: (2021)

Pretreatment plasma fibrinogen and serum albumin levels predict therapeutic efficacy of concurrent radiochemotherapy for esophageal squamous cell cancer
por: Wang, Jijin, et al.
Publicado: (2022)

A Clinical Scoring Model to Predict the Effect of Induction Chemotherapy With Definitive Concurrent Chemoradiotherapy on Esophageal Squamous Cell Carcinoma Prognosis
por: Li, Yang, et al.
Publicado: (2021)

Genomic Variations in Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma
por: Yasar, Hatime A
Publicado: (2023)

Family history of cancer is a prognostic factor for better survival in operable esophageal squamous cell carcinoma: A propensity score matching analysis
por: Zhang, Shuishen, et al.
Publicado: (2022)

Combination of Plasma-Based Metabolomics and Machine Learning Algorithm Provides a Novel Diagnostic Strategy for Malignant Mesothelioma
por: Li, Na, et al.
Publicado: (2021)

Neoadjuvant Immunotherapy Combined Chemotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Study
por: Hong, Zhi-Nuan, et al.
Publicado: (2021)

Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma
por: Han, Weiming, et al.
Publicado: (2022)

Predicting the efficacy of radiotherapy for esophageal squamous cell carcinoma based on enhanced computed tomography radiomics and combined models
por: Liu, Jihui, et al.
Publicado: (2023)

Plasma Circulating Tumor DNA Sequencing Predicts Minimal Residual Disease in Resectable Esophageal Squamous Cell Carcinoma
por: Liu, Tao, et al.
Publicado: (2021)

Relationship Between PTEN and Angiogenesis of Esophageal Squamous Cell Carcinoma and the Underlying Mechanism
por: Yang, Chenbo, et al.
Publicado: (2021)

Left versus right approach for middle and lower esophageal squamous cell carcinoma: A propensity score-matched study
por: Zhang, Xining, et al.
Publicado: (2022)

Definitive Simultaneous Integrated Boost Versus Conventional-Fractionated Intensity Modulated Radiotherapy for Patients With Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis
por: Li, Chen, et al.
Publicado: (2021)

The current state of artificial intelligence in endoscopic diagnosis of early esophageal squamous cell carcinoma
por: Pan, Yuwei, et al.
Publicado: (2023)

A Nomogram for Predicting Lymphovascular Invasion in Superficial Esophageal Squamous Cell Carcinoma
por: Ruan, Rongwei, et al.
Publicado: (2021)

Analysis of the risk factors of radiation pneumonitis in patients after radiotherapy for esophageal squamous cell carcinoma
por: Sun, Lu, et al.
Publicado: (2023)

Metabolomics of a cell line-derived xenograft model reveals circulating metabolic signatures for malignant mesothelioma
por: Gao, Yun, et al.
Publicado: (2022)

The prognosis value of CONUT and SIS score for recurrent or metastatic esophageal squamous cell carcinoma patients treated with second-line immunotherapy
por: Zhao, Xiao-Han, et al.
Publicado: (2023)

A radiomics nomogram for predicting postoperative recurrence in esophageal squamous cell carcinoma
por: Tong, Yahan, et al.
Publicado: (2023)

Pigment Epithelium-Derived Factor Promotes the Growth and Migration of Human Esophageal Squamous Cell Carcinoma
por: Tang, De-Rong, et al.
Publicado: (2020)

BRE Promotes Esophageal Squamous Cell Carcinoma Growth by Activating AKT Signaling
por: Jin, Fujun, et al.
Publicado: (2020)

Untargeted Metabolomics Analysis of Esophageal Squamous Cell Carcinoma Discovers Dysregulated Metabolic Pathways and Potential Diagnostic Biomarkers
por: Zhu, Zi-Jia, et al.
Publicado: (2020)

Optimal Range of Lymphadenectomy in Pathological Stage T1 and T2 Esophageal Squamous Cell Carcinoma
por: Wu, Hansheng, et al.
Publicado: (2021)

Salivary Metabolomics for Prognosis of Oral Squamous Cell Carcinoma
por: Ishikawa, Shigeo, et al.
Publicado: (2022)

Development of a prognostic nomogram and risk stratification system for upper thoracic esophageal squamous cell carcinoma
por: Lin, Yu, et al.
Publicado: (2023)

Outcomes and Prognostic Factors of Salvage Radiation for Postoperative Lymph Node Recurrence of Esophageal Squamous Cell Carcinoma
por: Zhang, Chi, et al.
Publicado: (2021)

Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma
por: Ju, Mengyang, et al.
Publicado: (2022)

Prognostic Value of Body Mass Index Stratified by Alcohol Drinking Status in Patients With Esophageal Squamous Cell Carcinoma
por: Chen, Shao-bin, et al.
Publicado: (2022)

The Plasma NAD(+) Metabolome Is Dysregulated in “Normal” Aging
por: Clement, James, et al.
Publicado: (2019)

Impact of Radiation Dose on Survival for Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemoradiotherapy
por: Yang, Yang, et al.
Publicado: (2020)

Integrative Analysis of Metabolomics and Transcriptomics Data Identifies Prognostic Biomarkers Associated With Oral Squamous Cell Carcinoma
por: Zuo, Lihua, et al.
Publicado: (2021)

Alteration of plasma metabolites associated with chemoradiosensitivity in esophageal squamous cell carcinoma via untargeted metabolomics approach
por: Zhang, Yaowen, et al.
Publicado: (2020)

Comprehensive Analysis of Competitive Endogenous RNAs Network, Being Associated With Esophageal Squamous Cell Carcinoma and Its Emerging Role in Head and Neck Squamous Cell Carcinoma
por: Yu, Donghu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_001119smv2arnsdb3l2bd33a5r